SCHEMBL11960244

SCHEMBL11960244

COc1cc(COC(C)=O)cc2c1[nH]c1ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP14 Q460N5 1/20 0.45
ALDH1A1 P00352 2/20 0.44
FTO Q9C0B1 1/20 0.44
MAPT P10636 3/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
GABRP O00591 1/20 0.43
GABRD O14764 1/20 0.43
GABRA1 P14867 1/20 0.43
GABRB1 P18505 1/20 0.43
GABRG2 P18507 1/20 0.43
GABRB3 P28472 1/20 0.43
GABRA5 P31644 1/20 0.43
GABRA3 P34903 1/20 0.43
GABRA2 P47869 1/20 0.43
GABRB2 P47870 1/20 0.43
GABRA4 P48169 1/20 0.43
GABRE P78334 1/20 0.43
GABRA6 Q16445 1/20 0.43
GABRG1 Q8N1C3 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Koenoline SCHEMBL29904331 0.81 TUBB4A (0.47) PARP14ALDH1A1FTOMAPTMEN1
Koenoline SCHEMBL6052281 0.81 TUBB4A (0.47) PARP14ALDH1A1FTOMAPTMEN1
SCHEMBL13697482 0.79 ALDH1A1 (0.55) ALDH1A1MAPTMEN1KMT2AGABRP
SCHEMBL27986588 0.78 FTO (0.47) ALDH1A1FTOMAPTMEN1KMT2A
Mukoeic Acid SCHEMBL29460309 0.75 FTO (0.56) ALDH1A1FTOMAPTMEN1KMT2A
SCHEMBL27929687 0.74 SLC22A6 (0.44) PARP14ALDH1A1FTOMAPTMEN1
Mukonine SCHEMBL17817163 0.74 FTO (0.73) ALDH1A1FTOMAPTGABRPGABRD
Mukonine SCHEMBL30880285 0.74 FTO (0.73) ALDH1A1FTOMAPTGABRPGABRD
SCHEMBL15203449 0.72 GABRP (0.46) PARP14ALDH1A1FTOMAPTMEN1
SCHEMBL11220480 0.72 MAPT (0.60) ALDH1A1FTOMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8519154-B2 Method for treatment of bronchial asthma COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2013-08-27 US disclosed
US-8519154-B2 Method for treatment of bronchial asthma COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2013-08-27 US disclosed
US-20120202868-A1 METHOD FOR TREATMENT OF BRONCHIAL ASTHMA COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2012-08-09 US disclosed
US-20120202868-A1 METHOD FOR TREATMENT OF BRONCHIAL ASTHMA COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2012-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202868-A1 METHOD FOR TREATMENT OF BRONCHIAL ASTHMA CHRM3, CHRM1, CHRM2 PARP14 2213/4885ALDH1A1 994/4885FTO 4386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.